Herbas VPB

Print
EN | LT
LT - THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS
EN - THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/513
A61K 31/53
A61K 31/5025
A61K 31/4184
A61P 35/00
European patent
(11) Number of the document 3102199
(13) Kind of document T
(96) European patent application number 15740207.4
Date of filing the European patent application 2015-01-21
(97) Date of publication of the European application 2016-12-14
(45) Date of publication and mention of the grant of the patent 2020-07-22
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/012244
Date 2015-01-21
PCT application publication
(87) Number WO 2015/112598
Date 2015-07-30
Priority applications
(30) Number Date Country code
201461929680 P 2014-01-21 US
Inventors
(72)
RASSOOL, Feyruz, US
BAYLIN, Stephen, US
ROBERT, Carine, FR
Grantee
(73) The Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218, US
University of Maryland, Baltimore, Office of Technology Transfer 620 W.Lexington Street, 4th Floor, Baltimore MD 21201, US
Title
(54) THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS
  THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS
Last update date 2021-04-30